Company: ZCARW
Filing Date: 2025-06-30
Form Type: 10-K
Source: 0001213900-25-059675
Chunk: 496

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-06-30
Form: 10-K
Item: Item 1A
Chunk 496
---
 were excluded from the computation of diluted loss
per share because their effect would have been anti-dilutive for the periods presented, or issuance of such shares is contingent upon
the satisfaction of certain conditions which were not satisfied by the end of the period.

    March 31, 2025  
    March 31, 2024 
  
    Stock options* 
     16  
     16 
  
    Restricted Stock Units (Refer Note 30) 
     17,966  
     - 
  
    Public warrants** 
     11,500,000  
     11,500,000 
  
    Private warrants*** 
     19,416  
     19,416 
  
    Unsecured convertible note (Refer Note 20) 
     -  
     1,653 
  
    Warrants issued in November 2024 and December 2024 offering (including Second and Third closing of December offering) (Refer Note 23) 
     12,335,519  
     - 
  
    Total 
     23,872,917  
     11,521,085 

*In 2012, the Company adopted its 2012 Equity Incentive Plan, under
which the Company may grant options and restricted stock to eligible participants. The plan is equity settled. Options are generally granted
for a term of ten years. Options have a graded vesting period of up to four years and the expenses are recorded on a straight-line basis
over the requisite service period for each separately vesting portion of the awards. The Company cancelled certain outstanding options
at the time of Reverse Recapitalization. The remaining 16 fully vested options were assumed by the Company on the Reverse Recapitalization
date, exercisable at exercise price ranging from $120 to $300.

**Prior to the Reverse Recapitalization date, the SPAC issued
Public Warrants. On the Closing Date, there were 11,500,000 Public Warrants issued and outstanding where 2,000 warrants are exercisable
into 1 share of Common stock of the Company for $11,420 per share.

***The common stock, preferred stock and SSCPN warrants have
been converted into private warrants of the Company at the Exchange Ratio at the time of Reverse Recapitalization. As of March 31, 2025,
each warrant is exercisable into one share of Common Stock of the Company at an exercise price of $